Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thymus-expressed chemokine promotes survival of PC12 cells via PI3K pathway.

Neurochemistry international·2011
Same author

Retinoic acid signaling sequentially controls visceral and heart laterality in zebrafish.

The Journal of biological chemistry·2011
Same author

A Drosophila model of the neurodegenerative disease SCA17 reveals a role of RBP-J/Su(H) in modulating the pathological outcome.

Human molecular genetics·2011
Same author

Overexpression and small molecule-triggered downregulation of CIP2A in lung cancer.

PloS one·2011
Same author

Antibiofouling hybrid dendritic Boltorn/star PEG thiol-ene cross-linked networks.

ACS applied materials & interfaces·2011
Same author

An absolute test for axicon surfaces.

Optics letters·2011
Same journal

Correction: Confidence Measurement Metrics in Multimodal Large Language Models for Ultrasound-Based Radiology Cases: Comparative Evaluation Study of Self-Reported, Consistency-Based, and Hybrid Methods.

Journal of medical Internet research·2026
Same journal

Centering Equity During Health Technology Innovation: Scoping Review of Methods and Research Adjustments to Promote Inclusive Coproduction.

Journal of medical Internet research·2026
Same journal

Comparative Effectiveness of AI-Assisted Telerehabilitation, Telerehabilitation, In-Person Care, and Usual Care for Chronic Nonspecific Low Back Pain: Bayesian Network Meta-Analysis.

Journal of medical Internet research·2026
Same journal

Effectiveness of WeChat Public Account Intervention Based on the Information-Motivation-Behavioral Skills Model Among College Students With Internet Addiction: Randomized Controlled Trial.

Journal of medical Internet research·2026
Same journal

Are Traditional Registries Becoming Obsolete in the Modern Digital Health Ecosystem?

Journal of medical Internet research·2026
Same journal

Detecting and Preventing Fraudulent Participation in Qualitative Research: Content Analysis of Two Multisite Studies.

Journal of medical Internet research·2026
See all related articles

Related Experiment Video

Updated: May 9, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

An easily accessible Web-based minimization random allocation system for clinical trials.

Lan Xiao1, Qiwen Huang, Veronica Yank

  • 1Research Institute, Palo Alto Medical Foundation, Palo Alto, CA, United States.

Journal of Medical Internet Research
|July 23, 2013
PubMed
Summary
This summary is machine-generated.

MinimRan is a new web-based tool that makes adaptive randomization easier for clinical trials. This system implements covariate-adaptive biased-coin randomization, improving trial efficiency and accessibility.

Keywords:
Kullback–Leibler divergenceWeb-basedadaptive randomizationminimizationrandomizationrandomized controlled trials

More Related Videos

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Related Experiment Videos

Last Updated: May 9, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Health Informatics

Background:

  • Adaptive allocation techniques like minimization are recommended for randomized clinical trials.
  • Implementation of minimization is limited by a lack of accessible tools.

Purpose of the Study:

  • To provide a robust, flexible, and accessible tool for covariate-adaptive biased-coin randomization.
  • To facilitate the use of minimization in clinical research.

Main Methods:

  • Developed MinimRan, a web-based random allocation system.
  • Implemented Pocock-Simon and 2-way minimization for categorical factors.
  • Included symmetric Kullback-Leibler divergence minimization for continuous and categorical factors.

Main Results:

  • The MinimRan system offers essential statistical and programming features.
  • Demonstrated system utility with randomization results from a completed trial.
  • The system supports single- and double-blind, single- and multicenter trials.

Conclusions:

  • The MinimRan system is expected to promote wider adoption of validated random allocation methods.
  • Aims to enhance the efficiency and practice of clinical research through accessible randomization tools.